Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HAE | Common Stock | Award | +3.08K | +13.78% | 25.4K | Aug 6, 2021 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. |
F2 | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
F3 | Includes 8,568 shares previously held by a grantor retained annuity trust, of which Mr. Dockendorff is the sole trustee, pursuant to an exempt transfer by such trust. |